Education
About Us
Working with TipRanks
Follow Us
Microbix Biosystms J (TSE:MBX)
TSX:MBX
Earnings Data
Report Date
Aug 13, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
―Last Year’s EPS
<0.01Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 15, 2025
|% Change Since: -5.56%
|Next Earnings Date:Aug 13, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance, increased margins, and successful operational advancements. However, challenges such as anticipated weaker sales in the second half and delays with a QAPs partner were noted. Despite these challenges, the company's strategic initiatives and financial strength position it well for future growth.Company Guidance
In the recent call discussing Microbix's Q2 2025 results, the company reported solid financial performance with total revenues of $5.3 million for the quarter and $11.4 million for the first half of the fiscal year. Gross margins improved significantly, reaching 60% in Q2, up 7% from the previous year. Net earnings for the first half stood at $900,000. Operationally, Microbix expanded its capabilities with recombinant antigen technology and made strides in the QAPs business, despite anticipating a more challenging second half due to a slowdown in sales to China. The balance sheet was strengthened, with a current ratio of 9.36 and a debt-to-equity ratio of 0.27. Additionally, the company exercised $2.7 million in warrants and options, enhancing its financial position. The company also highlighted progress in its therapeutic drug asset, Kinlytic urokinase, which is advancing well with its partner Sequel Pharma.Increased Revenue and Strong Margins
Q2 revenue reached $5.3 million with a 60% gross margin, up 7% from the previous year. For the first half, revenue was $11.4 million, with gross margins up by 10% year-over-year.
Operational and Financial Strength
The company exercised $2.7 million in warrants and options, paid down $1.15 million in mortgage, and doubled the credit line from $2 million to $4 million. Current ratio is at 9.36 and debt-to-equity ratio at 0.27.
Advancement in Recombinant Capabilities
Microbix has commissioned recombinant capabilities, opening substantial new markets for test ingredients and broadening the company's service offerings.
Global Leadership in HPV Screening
Progress in the QAPs business with leadership in screening for human papillomavirus and enabling global transition to molecular diagnostics.
Strong Partnerships and Program Milestones
Partnership with Sequel Pharma for the Kinylytic urokinase program and a major milestone achieved on May 5th, indicating the program is progressing well.
Operational Efficiency Gains
Manufacturing process upgrades have improved margins, reduced scrap rates, and enhanced yields, supported by digitization and automation.
TSE:MBX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:MBX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 15, 2025 | C$0.36 | C$0.34 | -5.56% |
Feb 13, 2025 | C$0.48 | C$0.48 | 0.00% |
Dec 19, 2024 | C$0.36 | C$0.37 | +2.78% |
Aug 14, 2024 | C$0.34 | C$0.34 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Microbix Biosystms J (TSE:MBX) report earnings?
Microbix Biosystms J (TSE:MBX) is schdueled to report earning on Aug 13, 2025, TBA Not Confirmed.
What is Microbix Biosystms J (TSE:MBX) earnings time?
Microbix Biosystms J (TSE:MBX) earnings time is at Aug 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:MBX EPS forecast?
Currently, no data Available